Company Filing History:
Years Active: 2018
Title: Eun Ju Jeon: Innovator in Protein Kinase Inhibition
Introduction
Eun Ju Jeon is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target protein kinases.
Latest Patents
Eun Ju Jeon holds a patent for "Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase." This invention relates to a novel bicyclic heteroaryl derivative, along with its pharmaceutically acceptable salts, hydrates, and solvates. The compound demonstrates improved inhibitory activity for protein kinases and is part of a pharmaceutical composition aimed at preventing or treating abnormal cell growth disorders.
Career Highlights
Throughout his career, Eun Ju Jeon has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His work has focused on innovative solutions to complex medical challenges.
Collaborations
Eun Ju Jeon has collaborated with several professionals in his field, including Seung Hyun Jung and Young Hee Jung. These collaborations have contributed to the advancement of research and development in pharmaceutical applications.
Conclusion
Eun Ju Jeon's work in developing novel compounds for protein kinase inhibition showcases his dedication to advancing medical science. His contributions are significant in the ongoing efforts to address abnormal cell growth disorders.